Skip to main content

Function

Catalyzes the deacetylation of N-acetylaspartic acid (NAA) to produce acetate and L-aspartate. NAA occurs in high concentration in brain and its hydrolysis NAA plays a significant part in the maintenance of intact white matter. In other tissues it acts as a scavenger of NAA from body fluids.

Involvement in disease

Canavan disease

CAND

A rare neurodegenerative condition of infancy or childhood characterized by white matter vacuolization and demyelination that gives rise to a spongy appearance. The clinical features are onset in early infancy, atonia of neck muscles, hypotonia, hyperextension of legs and flexion of arms, blindness, severe mental defect, megalocephaly, and death by 18 months on the average.

None

The disease is caused by variants affecting the gene represented in this entry.

Sequence similarities

Belongs to the AspA/AstE family. Aspartoacylase subfamily.

Tissue specificity

Brain white matter, skeletal muscle, kidney, adrenal glands, lung and liver.

Cellular localization

  • Cytoplasm
  • Nucleus

Alternative names

ACY2, ASP, ASPA, Aspartoacylase, Aminoacylase-2, ACY-2

Target type

Proteins

Primary research area

Neuroscience

Molecular weight

35735Da

We found 5 products in 2 categories

Primary Antibodies

Target

Reactive species

Proteins & Peptides

Target

Species of origin

Search our catalogue for 'ASPA' (5)

Products

ab223269

Anti-ASPA antibody [EPR22072]

Recombinant
RabMAb